Background Preventing thrombosis is an important part of atrial fibrillation (AF) treatment.
However, it may increase the risk of bleeding, and bleeding risk assessment tools' predictive …

Background There is uncertainty whether a focus on modifiable bleeding risk factors offers
better prediction of major bleeding than other existing bleeding risk scores. Methods This …

Our objective was to compare the diagnostic accuracy between the HAS‐BLED score and
any of HEMORR2HAGES, ATRIA, CHADS2, or CHA2DS2‐VASc scores in anticoagulated …

Risk scores in patients with atrial fibrillation (AF) based on clinical factors alone generally
have only modest predictive value for predicting high risk patients that sustain events …

Background The HAS-BLED (hypertension, abnormal renal/liver function, previous stroke,
bleeding history or predisposition, labile international normalized ratio [INR], elderly and …

Background Despite the clear net clinical benefit of oral anticoagulation for stroke prevention
in patients with atrial fibrillation (AF), the occurrence of major bleeding events may be …

Abstract Objective The HAS-BLED, ATRIA, and HEMORR 2 HAGES risk scores were
created to evaluate individual bleeding risk in atrial fibrillation (AF). We sought to estimate …

Background While modifiable bleeding risks should be addressed in all patients with atrial
fibrillation (AF), use of a bleeding risk score enables clinicians to 'flag up'those at risk of …

Objective Despite extensive use of oral anticoagulation (OAC) in patients with atrial
fibrillation (AF) and the increased bleeding risk associated with such OAC use, no handy …

Background: Oral anticoagulation (OAC) in patients with atrial fibrillation (AF) is a double‐
edged sword, because it decreases the risk of stroke at the cost of an increased risk of …